rs12899811
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_018668.5(VPS33B):c.1480-255T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.428 in 474,092 control chromosomes in the GnomAD database, including 51,610 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.46 ( 18811 hom., cov: 32)
Exomes 𝑓: 0.41 ( 32799 hom. )
Consequence
VPS33B
NM_018668.5 intron
NM_018668.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.478
Genes affected
VPS33B (HGNC:12712): (VPS33B late endosome and lysosome associated) Vesicle mediated protein sorting plays an important role in segregation of intracellular molecules into distinct organelles. Genetic studies in yeast have identified more than 40 vacuolar protein sorting (VPS) genes involved in vesicle transport to vacuoles. This gene is a member of the Sec-1 domain family, and encodes the human ortholog of rat Vps33b which is homologous to the yeast class C Vps33 protein. The mammalian class C vacuolar protein sorting proteins are predominantly associated with late endosomes/lysosomes, and like their yeast counterparts, may mediate vesicle trafficking steps in the endosome/lysosome pathway. Mutations in this gene are associated with arthrogryposis-renal dysfunction-cholestasis syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 15-91000846-A-G is Benign according to our data. Variant chr15-91000846-A-G is described in ClinVar as [Benign]. Clinvar id is 1267440.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.947 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS33B | NM_018668.5 | c.1480-255T>C | intron_variant | Intron 19 of 22 | ENST00000333371.8 | NP_061138.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS33B | ENST00000333371.8 | c.1480-255T>C | intron_variant | Intron 19 of 22 | 1 | NM_018668.5 | ENSP00000327650.4 | |||
ENSG00000284946 | ENST00000643536.1 | n.1480-255T>C | intron_variant | Intron 19 of 34 | ENSP00000494429.1 |
Frequencies
GnomAD3 genomes AF: 0.463 AC: 70274AN: 151908Hom.: 18761 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
70274
AN:
151908
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.412 AC: 132546AN: 322066Hom.: 32799 Cov.: 0 AF XY: 0.419 AC XY: 72535AN XY: 173136 show subpopulations
GnomAD4 exome
AF:
AC:
132546
AN:
322066
Hom.:
Cov.:
0
AF XY:
AC XY:
72535
AN XY:
173136
Gnomad4 AFR exome
AF:
AC:
5850
AN:
9086
Gnomad4 AMR exome
AF:
AC:
9460
AN:
15098
Gnomad4 ASJ exome
AF:
AC:
2748
AN:
9326
Gnomad4 EAS exome
AF:
AC:
18394
AN:
18774
Gnomad4 SAS exome
AF:
AC:
24171
AN:
44202
Gnomad4 FIN exome
AF:
AC:
5954
AN:
18128
Gnomad4 NFE exome
AF:
AC:
58440
AN:
188552
Gnomad4 Remaining exome
AF:
AC:
7020
AN:
17582
Heterozygous variant carriers
0
3399
6797
10196
13594
16993
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
506
1012
1518
2024
2530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.463 AC: 70386AN: 152026Hom.: 18811 Cov.: 32 AF XY: 0.470 AC XY: 34944AN XY: 74300 show subpopulations
GnomAD4 genome
AF:
AC:
70386
AN:
152026
Hom.:
Cov.:
32
AF XY:
AC XY:
34944
AN XY:
74300
Gnomad4 AFR
AF:
AC:
0.63539
AN:
0.63539
Gnomad4 AMR
AF:
AC:
0.573073
AN:
0.573073
Gnomad4 ASJ
AF:
AC:
0.300865
AN:
0.300865
Gnomad4 EAS
AF:
AC:
0.969884
AN:
0.969884
Gnomad4 SAS
AF:
AC:
0.56805
AN:
0.56805
Gnomad4 FIN
AF:
AC:
0.338233
AN:
0.338233
Gnomad4 NFE
AF:
AC:
0.316705
AN:
0.316705
Gnomad4 OTH
AF:
AC:
0.464387
AN:
0.464387
Heterozygous variant carriers
0
1679
3358
5038
6717
8396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
614
1228
1842
2456
3070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2715
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 31, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at